European Archives - Page 265 of 899 - European Medical Journal

Aficamten: A Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy

Cardiac myosin inhibitors (CMI) are the first medications specifically targeting the underlying pathophysiology of hypertrophic cardiomyopathy

EMJ Cardiology 10 [Supplement 1] 2022

A leading expert from the field of cardiology and cardiovascular disease provided their perspectives on Phase II data and the design…

EMJ Microbiology 3.1 2022 Feature Image

ECCMID 2022 Abstract Highlights

The following highlights spotlight several fascinating and timely abstracts presented at the 32nd ECCMID…

EMJ Microbiology 3.1 2022 Feature Image

Review of the 32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2022

A PIONEERING hybrid format was adopted by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for the 32nd Euro…

EMJ Microbiology 3.1 2022 Feature Image

EMJ Microbiology & Infectious Diseases 3.1 2022

Welcome to our latest edition of EMJ Microbiology and Infectious Diseases, sharing novel case studies and outlining key advances in…

EMJ Microbiology 3.1 2022 Feature Image

Past, Present, and Future of Pandemics: Preparedness and First Defences

As expected, debate and expert discussion at the 32nd European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in April …

EMJ Microbiology 3.1 2022 Feature Image

Acute Bacterial Skin and Skin Structure Infections: Advantages and Disadvantages of Early Discharge and Outpatient Parenteral Antibiotic Therapy

Acute bacterial skin and skin structure infections (ABSSSI) can require long periods of antibiotic therapy. If an ABSSSI…

EMJ Microbiology 3.1 2022 Feature Image

Factors Associated with Rehospitalisation for Cellulitis and How to Mitigate Against Them

Gavin Barlow, Hull York Medical School, UK, spoke with the EMJ about risk factors for the bacterial infection cellulitis…

Reassessing Paediatric Allergen-Specific Immunotherapy Studies

Allergen-specific immunotherapy (AIT) works well both in children and adults. An often-alleged gap between the level of evidence of AIT efficacy…

Getting to grips with customer experience

Join Isabel and Jade in kicking off Season 5 of the GOLD podcast with an interview with Philippe Kirby, Global Head of Channel Engagement and Execution, MSD.